Home > News > Gene technology moves forward at Mirus Bio
July 30th, 2007
Gene technology moves forward at Mirus Bio
Abstract:
Mirus later developed two methods for delivery intravenously via the veins, similar to administering an IV. Such a procedure can be done in 10 to 15 minutes, and is similar to giving blood, except that the material goes into the body rather than being withdrawn.
The first, "hydrodynamic intravascular injection," involves pressurized delivery of nucleic acids through the bloodstream to surrounding cells and tissues. This enables regional delivery to a limb or other targeted area of the body.
The second delivery platform involves nanoparticle formulations that are delivered via a standard IV injection -- no pressure is involved -- and can be targeted to specific tissues and cells without being limited to the area of injection.
Source:
madison.com
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||